Piper Sandler lowers Affirm stock price target to $105 on valuation

Piper Sandler cut its price target on Affirm (AFRM) to $105 from $115, citing valuation changes, while raising its fiscal 2027 EPS estimate to $1.92. Affirm's Q1 results beat expectations with $1.26B revenue and $0.47 EPS, but shares fell 8% after-hours. Analysts note potential upside, with revenue growth of 32% and predicted profitability. Other analysts raised targets to $97 (Scotiabank) and $100 (Needham).

Original reporting
Published Nov 6, 2026, 2:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 2:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AFRM
Bullish
high confidence
Mentioned
$AFRM
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AFRMBullishMed
01

Why it matters

The earnings beat and target adjustments provide a fresh catalyst for price movement, though recent share decline reflects investor caution.

02

Market read

Affirm's earnings beat and revised targets create a short‑term trading opportunity amid broader fintech sentiment.

03

What to watch

Potential headwinds from rising interest rates and credit trends could offset earnings momentum.

Relevance 7/10Novelty 7/10Timing: after‑hours today

Background

Affirm disclosed Q1 fiscal 2027 results, beating expectations, and raised its growth floor, prompting analyst target revisions.

Company-level read

Ticker impact

$AFRMBullishHigh confidence
Context

Piper Sandler lowered its price target to $105 and affirmed an Overweight rating after reporting that Affirm's Q1 fiscal 2027 earnings beat expectations, with EPS $0.47 and revenue $1.26B.

Expected impact

likely upward pressure as traders price in the new $105 target and earnings beat

Evidence & confidence

The fresh earnings numbers and target cut are primary disclosures; the stock fell on the news but the lower target implies valuation support.

Market effects

Fintech sector may see modest re‑rating as analysts adjust valuations based on higher earnings multiples.

U.S. markets could see slight positive bias in consumer finance stocks.

Limited to U.S. equity investors focused on fintech.

Counterpoint

The 8% post‑earnings drop may signal lingering concerns over costs and credit risk, suggesting caution.

Key entities

  • Piper Sandler

    Lowered price target to $105, maintained Overweight rating.

  • Scotiabank

    Raised price target to $97.

  • Needham

    Reiterated Buy rating with $100 target.

Related articles

$AFRMHighAI 8/10

Affirm Posts Its Best Quarter Ever as Visa and Mastercard Wobble

Affirm reported fiscal Q1 2027 earnings with GAAP EPS of $0.47, beating estimates, and revenue of $1.26B, up 35% YoY. Gross merchandise volume rose 34% to $14.4B. The company raised its full-year outlook, citing strong growth in its card services and active users. Affirm's performance contrasts with declines in Visa and Mastercard shares amid stablecoin concerns.

$AFRMMed

Affirm (AFRM) Q1 2027 Earnings Call Transcript

Affirm (AFRM) executives discussed growth prospects, funding costs, and agentic shopping during Q1 2027 earnings call. Max Levchin expects 30%+ growth for a long time, citing low e-commerce penetration. Robert O'Hare confirmed a 30% growth floor for the year. Levchin also highlighted Affirm's focus on agentic shopping, emphasizing personalized transaction pricing. Funding costs rose 27 bps quarter-over-quarter but remain down year-on-year, with 70% of on-balance sheet funding fixed-rate.

$AFRMHigh

Scotiabank raises Affirm stock price target to $97 on growth outlook

Scotiabank raised its price target on Affirm (AFRM) to $97 from $95, maintaining a Sector Outperform rating. The fintech company reported 30% gross merchandise volume growth, a 4.3% transaction cost take rate, and raised its fiscal 2027 growth floor to 30%. Affirm's Q1 2027 earnings beat expectations with $0.47 EPS on $1.26B revenue. Management noted increased allowance rates and delinquencies but highlighted better loan sale pricing.

$AFRMMed

Needham reiterates Affirm stock rating citing strong growth

Needham reiterated a Buy rating and $100 price target on Affirm (AFRM) after Q1 results beat estimates. Revenue rose 32% to $4.26B, with earnings of $5.53 per share. Affirm Card showed strong growth, but shares fell due to credit cost concerns. InvestingPro notes volatility and potential undervaluation. Q1 2027 earnings of $0.47 per share on $1.26B revenue exceeded expectations, with a 34% GMV increase.